Moa Life Plus

Moa Life Plus FCF Yield

The Free Cash Flow Yield of Moa Life Plus (142760.KQ) as of Oct 30, 2026 is -14.03 %. In the previous year, Free Cash Flow Yield was -3.53 % — a change of 297.53% (lower).

FCF Yield

-14.03 %

YoY

297.53%

Last updated:

Free Cash Flow Yield of Moa Life Plus is 2025 -14.03 % . Free Cash Flow Yield of Moa Life Plus was 2024 -3.53 % . It decreases by 297.53% lower compared to the previous year.

The Moa Life Plus FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
-29.11 KRW
Jan 1, 2019
-58.31 KRW
Jan 1, 2020
-52.66 KRW
Jan 1, 2021
-15.44 KRW
Jan 1, 2022
-50.64 KRW
Jan 1, 2023
13.15 KRW
Jan 1, 2024
-3.53 KRW
Jan 1, 2025
-14.03 KRW
The Moa Life Plus FCF Yield history
YEARFCF YieldYoY
-14.03 %+297.53%
-3.53 %-126.83%
13.15 %-125.97%
-50.64 %+228.08%
-15.44 %-70.69%
-52.66 %-9.69%
-58.31 %+100.28%
-29.11 %+15.45%
-25.22 %+21.69%
-20.72 %+75.54%
-11.81 %+9.44%
-10.79 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Moa Life Plus Stock analysis

What does Moa Life Plus do? BL Corp. develops biopharmaceutical products and manufactures health functional foods and functional cosmetics. The company distributes Glu 100 Tablets, CellribonQ, and GentaQ to general hospitals and pharmacies. It generates revenue through the sale of these pharmaceuticals and health-related products to healthcare providers and retail outlets. The firm's product portfolio includes Glu 100 Tablets, CellribonQ, and GentaQ, which are distributed to general hospitals and pharmacies. These products are sold as part of the company's pharmaceutical and medical supplies distribution business. Revenue is derived from the sale of these branded medicines and health functional products. BL Corp. focuses on the distribution of specific branded pharmaceuticals and health functional products. The company's primary customers are general hospitals and pharmacies, which purchase Glu 100 Tablets, CellribonQ, and GentaQ for resale or direct use in healthcare settings. Moa Life Plus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Moa Life Plus stock

Free Cash Flow Yield of Moa Life Plus is -14.03 % in 2025.

Free Cash Flow Yield of Moa Life Plus changed from -3.53 % to -14.03 %, representing a 297.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Moa Life Plus since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Moa Life Plus with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Moa Life Plus

All Key Metrics — Moa Life Plus